Nigeria includes bleeding disorders in national policy and strategic plan

Nigeria includes bleeding disorders in national policy and strategic plan

For over the last five years, the Haemophilia Foundation of Nigeria (HFN), in collaboration with the World Federation of Hemophilia (WFH), has engaged the federal government of Nigeria through the Ministry of Health to advocate for the adequate care of people with bleeding disorders (PWBDs) in the country.

Also available in: Français Español

For over the last five years, the Haemophilia Foundation of Nigeria (HFN), in collaboration with the World Federation of Hemophilia (WFH), has engaged the federal government of Nigeria through the Ministry of Health to advocate for the adequate care of people with bleeding disorders (PWBDs) in the country. These efforts have now come to fruition, as the Nigerian government will officially include bleeding disorders in its health policy and strategic plan.

A proposal was developed by the WFH and the HFN, and was reviewed by representatives from the Nigerian Federal Ministry of Health and the World Health Organization (WHO). The ministry then held a five-day meeting with representatives from the WFH, the HFN, the WHO, and other stakeholders, to draft a new national noncommunicable diseases (NCDs) policy. Stakeholders present during the review meeting included the WHO, the Ministry of Health, the HFN, experts representing the interests of the five other NCDs (hypertension, diabetes, cardiovascular diseases, mental health and sickle cell disease), and other stakeholders.

The meeting was officially opened by Oyinlola Sanni, MD, National Coordinator for NCDs. Alayo Sopekan, MD, the federal sickle cell and bleeding disorders desk officer and deputy director NCD, explained the need for the inclusion of bleeding disorders into the NCD policy: “It is evident from the data and advocacy efforts that there are citizens in the country that have been diagnosed with hemophilia and other bleeding conditions. It is therefore only logical for the government to include these conditions as one of its NCDs priorities.”

Participants were broken into groups and asked to review the different sections of the previous policy and make recommendations for changes. The HFN was then asked to present their case as to why inherited bleeding disorders should be added into the policy. Megan Adediran—President of the HFN and WFH Board Lay Member—presented the status of bleeding disorders in the country—including expected prevalence versus the actual number of identified individuals. She then went over the debilitating effects of lack of treatment, such as morbidity, disability and mortality. It was unanimously agreed during the meeting that bleeding disorders had been underserved in Nigeria.

Participants agreed upon the following for inclusion in the inherited bleeding disorders section of the national health policy:

  • Setting-up a national structure to disseminate information
  • Ensuring early detection as well as proper medical care
  • Promoting comprehensive care and improving inherited bleeding disorders management

The government is planning a validation workshop where subject matter experts and practitioners will review the draft policy before it is presented for final approval and implementation.

The WFH would like to thank the many individuals who contributed to the success of this endeavour: Tessy Nwagha, MD; Sarah Olabode, MD; Rotimi Kareem, PhD; Florence Olukokun; Amaka Anoke; Idris Aderinto; Megan Adediran; and Alayo Sopekan, MD, federal bleeding disorders desk officer, and other HFN and state representatives. Special thanks go to Osagie Emmauel Ehanire, MD, the Nigerian Minister of Health, whose support contributed greatly to the realization of this accomplishment.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.